|
|
|
Volumn 73, Issue 4, 2001, Pages 362-364
|
|
Relapse rates amongst the multidrug therapy-treated leprosy patients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DAPSONE;
LEPROSTATIC AGENT;
AGE;
CLINICAL EXAMINATION;
CLINICAL PROTOCOL;
COMBINATION CHEMOTHERAPY;
COMPARATIVE STUDY;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG EXPOSURE;
FEASIBILITY STUDY;
FOLLOW UP;
HEALTH PROGRAM;
HOSPITAL;
HUMAN;
IMMUNITY;
LEPROSY;
LEPROSY CONTROL;
LETTER;
MAJOR CLINICAL STUDY;
MICROBIOLOGICAL EXAMINATION;
MONOTHERAPY;
PATIENT CARE;
PATIENT MONITORING;
POPULATION RISK;
PRACTICE GUIDELINE;
RECURRENCE RISK;
RECURRENT DISEASE;
RETROSPECTIVE STUDY;
SMEAR;
WORLD HEALTH ORGANIZATION;
DRUG THERAPY, COMBINATION;
HUMANS;
LEPROSTATIC AGENTS;
LEPROSY;
RECURRENCE;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
|
EID: 0035717777
PISSN: 02549395
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (3)
|
|
References (6)
|
